Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

New developments: chloroquine-resistance in Plasmodium falciparum.
WARHURST, D;
2001
Drug resistance updates, (2001).4 3 10.1054/drup.2001.0194.
In vitro and in vivo activities of aminoadamantane and aminoalkylcyclohexane derivatives against Trypanosoma brucei.
KELLY, JM; Quack, G; MILES, MM;
2001
Antimicrobial agents and chemotherapy, (2001).45 5 10.1128/AAC.45.5.1360-1366.2001.
A molecular marker for chloroquine-resistant falciparum malaria.
WARHURST, DC;
2001
The New England journal of medicine, (2001).344 4 10.1056/NEJM200101253440411.
Mode of action of artemether lumefantrine (COARTEM): The sole, fixed, oral ADCC and its role in combatting multidrug resistance.
WARHURST, DC; Adagu, IS; Beck, HP; Duraisingh, MT; Kirby, GC; Von Seidlein, L; Wright, CW;
2001
The Southeast Asian journal of tropical medicine and public health, (2001).32 suppl.
Monitoring antimalarial drug resistance (report of a WHO Consultation).
Bloland, P; D'ALESSANDRO, U; Ringwald, P; Watkins, W (Technical Advisers: Warhurst, D; Et al),;
2001
, WHO (Geneva) (2001).WHO/CD,
Interventions against antimicrobial resistance - a review of the literature and exploration of modelling cost effectiveness.
SMITH, R; Coast, J; Millar, M; Wilton, P; Karcher, A.-, M;
2001
, Global Forum for Health Research, World Health Organisation (Geneva) (2001).
Antimicrobial resistance: can economics help?.
Coast, J; SMITH, R;
2001
Eurohealth, (2001).7 2